Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes

ClinicalTrials.gov ID: NCT06334133

Public ClinicalTrials.gov record NCT06334133. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 1:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Cadisegliatin as Adjunctive Therapy in Type 1 Diabetes: A 26-Week Double-Blind, Randomized, Placebo-Controlled Phase 3 Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 3 trial of cadisegliatin as adjunctive therapy to insulin in participants with Type 1 Diabetes Mellitus.

Study identification

NCT ID
NCT06334133
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
vTv Therapeutics
Industry
Enrollment
150 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 14, 2024 (Actual)
Primary completion
Apr 2027 (Estimated)
Completion
May 2027 (Estimated)
Last update posted
Jul 28, 2026

2024 – 2027

United States locations

U.S. sites
51
U.S. states
23
U.S. cities
47
Facility City State ZIP Site status
Scottsdale Clinical Trials Scottsdale Arizona 85260 —
Baptist Health Center for Clinical Research Little Rock Arkansas 72205 —
Amicis Research Center Granada Hills California 91344 —
AME Clinical Research Huntington Beach California 92647 —
310 Clinical Research Inglewood California 90301 —
Scripps Whittier Diabetes Institute La Jolla California 92037 —
IMAX Clinical Trials La Palma California 90623 —
Paradigm Clinical Research - Modesto Modesto California 95355 —
Paradigm Clinical Research Centers LLC San Diego California 92108 —
Acclaim Clinical Research San Diego California 92120 —
The Lundquist Institute Torrance California 90502 —
Focus Clinical Research West Hills California 91307 —
Denver Endocrinology Diabetes and Thyroid Center Englewood Colorado 80113 —
BayCare Health Systems Clearwater Florida 33756 —
Metabolic Research Institute, Inc West Palm Beach Florida 33413 —
Atlanta Diabetes Associates Atlanta Georgia 30318 —
Centricity Research - Columbus Columbus Georgia 31904 —
The Jones Center Clinical Research, LLC Macon Georgia 31210 —
Paradigm Clinical Research Boise Idaho 83709 —
DM Clinical Research Indianapolis Indiana 46254 —
Accellacare - McFarland Ames Iowa 50010 —
Iowa Diabetes and Endocrinology Research Center West Des Moines Iowa 50265 —
Johnson County Clin-Trials, LLC Lenexa Kansas 66219 —
MedStar Good Samaritan Hospital Baltimore Maryland 21239 —
Massachusetts General Hospital Diabetes Research Center Boston Massachusetts 02114 —
Profound Research LLC Farmington Hills Michigan 48334 —
Excel Clinical Research Las Vegas Nevada 89109 —
Palm Research Center Las Vegas Nevada 89128 —
Vector Clinical Trials Reno Nevada 89511 —
AMC Community Endocrinology Albany New York 12203 —
Jacobi Medical Center The Bronx New York 10461 —
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27514 —
Javarra Inc. Charlotte North Carolina 28210 —
Physician's East PA Greenville North Carolina 27834 —
Centricity Research Morehead City Multispecialty Morehead City North Carolina 28557 —
Diabetes & Endocrinology Associates of Stark County, Inc Canton Ohio 44718 —
John Muir Physician Network Clinical Research Center Concord Ohio 94520 —
Velocity Clinical Research Medford Oregon 97504 —
University of Pennsylvania Perelman Center for Advanced Medicine Philadelphia Pennsylvania 19104 —
Circle Clinical Research Sioux Falls South Dakota 57104 —
Texas Diabetes and Endocrinology, P.A Austin Texas 78731 —
Velocity Clinical Research - Dallas Dallas Texas 75230 —
Tekton Research, LLC McKinney Texas 75069 —
SMS Clinical Research LLC Mesquite Texas 75149 —
Southern Endocrinology Associates PA Mesquite Texas 75149 —
Diabetes & Glandular Disease Clinic, P.A. San Antonio Texas 78229 —
Consano Clinical Research Shavano Park Texas 78231 —
Wasatch Clinical Research, LLC Salt Lake City Utah 84107 —
University of Washington Diabetes Institute Seattle Washington 98109 —
Citta Clinical Research, LLC Spokane Washington 99202 —
Velocity Clinical Research - Spokane Spokane Washington 99218 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06334133, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 28, 2026 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06334133 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →